LMR Partners »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by LMR Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by LMR Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $25M 15M 1.65

More positions owned by LMR Partners

Select Sector Spdr Tr Indl Call Option (XLI)
Strategy Cl A New (MSTR)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Silver Tr Ishares Call Option (SLV)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation Put Option (NVDA)
Gamestop Corp Cl A Put Option (GME)
Alibaba Group Hldg Sponsored Ads (BABA)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Pdd Holdings Sponsored Ads Call Option (PDD)
Coinbase Global Com Cl A (COIN)
Echostar Corp Note 3.875%11/3 (Principal)
Kellogg Company Put Option (K)
Echostar Corp Cl A Put Option (SATS)

View all positions for LMR Partners

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Manufacturers Life Insurance Company
FMR
MacKay Shields
LMR Partners
Parallax Volatility Advisers
Morgan Stanley
BlackRock
Lord, Abbett & Co
Universal- Beteiligungs- und Servicegesellschaft mbH
SSI Investment Management
Jpmorgan Chase & Co
Nicholas Investments Partners

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1